FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vera Hirsh

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Chee Khoon Lee; Siow Ming Lee; Jemela Anne Osorio Sanchez; Eng Huat Tan; Sumitra Thongprasert; Chun-Ming Tsai; Vu Van Vu; Joseph Siu Kie Au; Chris Brown; Da Tong Chu; Val Gebski; Richard J Gralla; Vera Hirsh; James Chung-Man Ho; Akira Inoue; Adel Zaatar; James Chih-Hsin Yang
Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis.
Giorgio Vittorio Scagliotti; Salvatore Siena; Philippe Solal-Celigny; Huei Wang; Penella J Woll; Arun Balakumaran; Tudor-Eliade Ciuleanu; José Angel García-Sáenz; David H Henry; Vera Hirsh; Vladimir Kanarev; Maciej Krzakowski; Lara Lipton; Christian Manegold; Nilesh D Mehta; José Rodrigues Pereira; Kumar Prabhash; Gladys Rodriguez; Ira Jacobs
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
Frances A Shepherd; José Rodrigues Pereira; tudor ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Erlotinib in previously treated non-small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vera Hirsh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chee Khoon Lee; Siow Ming Lee; Jemela Anne Osorio Sanchez; Eng Huat Tan; Sumitra Thongprasert; Chun-Ming Tsai; Vu Van Vu; Joseph Siu Kie Au; Chris Brown; Da Tong Chu; Val Gebski; Richard J Gralla; Vera Hirsh; James Chung-Man Ho; Akira Inoue; Adel Zaatar; James Chih-Hsin Yang
Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis.
Journal of the National Cancer Institute 2013;105(9):595-605.
2012: Giorgio Vittorio Scagliotti; Salvatore Siena; Philippe Solal-Celigny; Huei Wang; Penella J Woll; Arun Balakumaran; Tudor-Eliade Ciuleanu; José Angel García-Sáenz; David H Henry; Vera Hirsh; Vladimir Kanarev; Maciej Krzakowski; Lara Lipton; Christian Manegold; Nilesh D Mehta; José Rodrigues Pereira; Kumar Prabhash; Gladys Rodriguez; Ira Jacobs
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(12):1823-9.
2005: Frances A Shepherd; José Rodrigues Pereira; tudor ciuleanu; Eng Huat Tan; Vera Hirsh; Sumitra Thongprasert; Daniel Campos; Savitree Maoleekoonpiroj; Michael Smylie; Renato Martins; Maximiliano van Kooten; Mircea Dediu; Brian Findlay; Dongsheng Tu; Dianne Johnston; Andrea Bezjak; Gary Clark; Pedro Santabárbara; Lesley Seymour
Erlotinib in previously treated non-small-cell lung cancer.
The New England journal of medicine 2005;353(2):123-32.
2004: Vera Hirsh; N Simon Tchekmedyian; Lee S Rosen; Ming Zheng; Yong-Jiang Hei
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications.
Clinical lung cancer 2004;6(3):170-4.
2004: Lee S Rosen; David Gordon; N Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; Maciej Krzakowski; Marek Pawlicki; Paul De Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John Seaman
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.
Cancer 2004;100(12):2613-21.
2003: Lee S Rosen; David Gordon; Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; Maciej Krzakowski; Marek Pawlicki; Paul de Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John Seaman
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3150-7.
2003: Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Alfonso Illiano; Francovito Piantedosi; Sergio Federico Robbiati; Luigi Manzione; Santi Barbera; Luciano Frontini; Enzo Veltri; Brian Findlay; Silvio Cigolari; Robert Myers; Giovanni Pietro Ianniello; Vittorio Gebbia; Giampietro Gasparini; Sergio Fava; Vera Hirsh; Andrea Bezjak; Lesley Seymour; Francesco Perrone
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2002: Frances A Shepherd; Giuseppe Giaccone; Lesley Seymour; Channa Debruyne; Andrea Bezjak; Vera Hirsh; Michael Smylie; Sheldon Rubin; Heidi Martins; Alan Lamont; Maciej Krzakowski; Anna Sadura; Benny Zee
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4434-9.